Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Motzer

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Selecting patients with cisplatin-resistant germ cell tumors for high-dose chemotherapyR J Motzer
Bone Marrow Transplantation|September 1, 1996
High-dose chemotherapy for germ cell tumors (GCT): Memorial Sloan Kettering Cancer CenterR J Motzer
Cancer|July 1, 1993
Optimal treatment for advanced seminoma?R J Motzer
Seminars in Urologic Oncology|February 1, 1996
Adjuvant chemotherapy for stage II nonseminomatous testicular cancer: what is its role?R J Motzer
Seminars in Oncology|November 5, 1997
Paclitaxel in salvage therapy for germ cell tumorsR J Motzer
Seminars in Oncology|December 1, 1995
Adjuvant chemotherapy for patients with stage II nonseminomatous testis cancerR J Motzer
Seminars in Oncology|March 4, 2000
Paclitaxel (Taxol) combination therapy for resistant germ cell tumorsR J Motzer
Seminars in Oncology|April 18, 2000
Renal cell carcinoma: progress against an elusive tumorR J Motzer
The Journal of Urology|January 27, 2000
Systemic therapy for renal cell carcinomaR J Motzer, P Russo
Der Urologe. Ausg. A|May 19, 2004
Predicting survival of patients with metastatic renal cell carcinomaR J Motzer, M Mazumdar
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Selecting patients with cisplatin-resistant germ cell tumors for high-dose chemotherapyR J Motzer
Bone Marrow Transplantation|September 1, 1996
High-dose chemotherapy for germ cell tumors (GCT): Memorial Sloan Kettering Cancer CenterR J Motzer
Cancer|July 1, 1993
Optimal treatment for advanced seminoma?R J Motzer
Seminars in Urologic Oncology|February 1, 1996
Adjuvant chemotherapy for stage II nonseminomatous testicular cancer: what is its role?R J Motzer
Seminars in Oncology|November 5, 1997
Paclitaxel in salvage therapy for germ cell tumorsR J Motzer
Seminars in Oncology|December 1, 1995
Adjuvant chemotherapy for patients with stage II nonseminomatous testis cancerR J Motzer
Seminars in Oncology|March 4, 2000
Paclitaxel (Taxol) combination therapy for resistant germ cell tumorsR J Motzer
Seminars in Oncology|April 18, 2000
Renal cell carcinoma: progress against an elusive tumorR J Motzer
The Journal of Urology|January 27, 2000
Systemic therapy for renal cell carcinomaR J Motzer, P Russo
Der Urologe. Ausg. A|May 19, 2004
Predicting survival of patients with metastatic renal cell carcinomaR J Motzer, M Mazumdar
Pageof 16